TCM
LGND icon

Tygh Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Tygh Capital Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-55,286
Closed -$3.43M – 93
2020
Q4 		$3.43M Sell
55,286
-84,167
-60% -$4.8M 0.53% 74
2020
Q3 		$8.29M Sell
139,453
-61,084
-30% -$4.17M 1.57% 23
2020
Q2 		$14M Sell
200,537
-42,786
-18% -$2.71M 2.92% 2
2020
Q1 		$11M Buy
243,323
+154,081
+173% +$8.73M 2.47% 5
2019
Q4 		$5.81M Buy
89,242
+36,747
+70% +$2.46M 0.96% 49
2019
Q3 		$3.26M Sell
52,495
-43,425
-45% -$2.73M 0.58% 65
2019
Q2 		$6.83M Buy
95,920
+18,117
+23% +$1.33M 1.16% 39
2019
Q1 		$6.1M Sell
77,803
-50,730
-39% -$3.84M 1.07% 45
2018
Q4 		$10.9M Buy
128,533
+66,726
+108% +$7.11M 2.28% 8
2018
Q3 		$10.6M Sell
61,807
-18,011
-23% -$2.72M 1.73% 17
2018
Q2 		$10.3M Sell
79,818
-1,156
-1% -$129K 1.75% 12
2018
Q1 		$8.34M Buy
80,974
+2,688
+3% +$266K 1.58% 19
2017
Q4 		$6.69M Sell
78,286
-46,375
-37% -$4.02M 1.26% 24
2017
Q3 		$10.6M Buy
124,661
+29,836
+31% +$2.36M 2.12% 4
2017
Q2 		$7.18M Buy
+94,825
New +$6.63M 1.63% 13

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Tygh Capital Management's LGND Position: Q1 2021 in Review

Tygh Capital Management sold out of Ligand Pharmaceuticals (LGND) in Q1 2021, closing a stake of 55,286 shares — an estimated $3.43M sold.

Tygh Capital Management first reported a position in LGND in Q2 2017 and held it in 15 quarters. The position peaked at $14M in Q2 2020. 228 funds tracked by Wall St. Rank hold LGND as of Q1 2021.

  • Tygh Capital Management reported no remaining Ligand Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Tygh Capital Management sold 55,286 Ligand Pharmaceuticals shares in Q1 2021, an estimated $3.43M.
  • Tygh Capital Management first reported a position in Ligand Pharmaceuticals in Q2 2017 and held it in 15 quarters.
  • Tygh Capital Management's Ligand Pharmaceuticals position peaked at $14M in Q2 2020.
  • 228 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2021.

Based on Tygh Capital Management's 13F filing for Q1 2021, filed 10 May 2021.